PAXIL CR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paxil Cr, and what generic alternatives are available?
Paxil Cr is a drug marketed by Apotex and is included in one NDA.
The generic ingredient in PAXIL CR is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Paxil Cr
A generic version of PAXIL CR was approved as paroxetine hydrochloride by APOTEX on July 30th, 2003.
Summary for PAXIL CR
Pharmacology for PAXIL CR
Drug Class | Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PAXIL CR
Paragraph IV (Patent) Challenges for PAXIL CR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
PAXIL CR | Extended-release Tablets | paroxetine hydrochloride | 37.5 mg | 020936 | 1 | 2009-05-19 |
PAXIL CR | Extended-release Tablets | paroxetine hydrochloride | 25 mg | 020936 | 1 | 2005-09-09 |
US Patents and Regulatory Information for PAXIL CR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-001 | Feb 16, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-002 | Feb 16, 1999 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-003 | Dec 6, 2000 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PAXIL CR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-001 | Feb 16, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-001 | Feb 16, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-002 | Feb 16, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-001 | Feb 16, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-002 | Feb 16, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Apotex | PAXIL CR | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020936-003 | Dec 6, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PAXIL CR
See the table below for patents covering PAXIL CR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1315949 | ⤷ Try a Trial | |
Eurasian Patent Organization | 003775 | КОМПОЗИЦИИ С КОНТРОЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ ПАРОКСЕТИНА (PAROXETINE CONTROLLED RELEASE COMPOSITIONS) | ⤷ Try a Trial |
Slovakia | 14396 | PAROXETINEHYDROCHLORIDE, PREPARATION METHOD THEREOF AND USE | ⤷ Try a Trial |
United Kingdom | 9914709 | ⤷ Try a Trial | |
Morocco | 23802 | ⤷ Try a Trial | |
Peru | 16098 | FORMULACIONES QUE CONTIENEN PAROXETINA | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |